Vical Initiates Phase 2 Trial of VL-2397 Antifungal for Invasive Aspergillosis

Vical Initiates Phase 2 Trial of VL-2397 Antifungal for Invasive Aspergillosis

READ FULL TEXT

Leave a Reply

Your email address will not be published.